BLOG/🇺🇸United States··daily

S&P 500 Healthcare Sector SEC Filings — April 15, 2026

USA S&P 500 Healthcare

14 high priority36 medium priority50 total filings analysed

Executive Summary

Across 50 filings in the S&P 500 Healthcare stream (though including cross-sector context via 13F holdings), dominant patterns emerge from 25+ 13F-HR disclosures showing institutional portfolios heavily weighted to mega-cap tech (AAPL, MSFT, NVDA averaging top 3 holdings at 10-25% allocation) and broad ETFs (e.g., SCHB, SPY), indicating conviction in resilient large-caps amid Q1 2026 positioning. Healthcare-specific highlights include Amgen's robust 10% YoY revenue/sales growth with 18 products at record sales and 14 exceeding $1B, Wave Life Sciences' redomiciliation to Delaware mid-2026 for cost savings, and Integra Lifesciences' $150M A/R facility extension to 2029 signaling liquidity strength. Period-over-period trends show mixed small-cap results (e.g., Citi Trends sales +8.9% YoY to profitability vs Tradewinds revenue -22% YoY, op ex +368%), while financials like PNC posted NII +6% QoQ/loans +7% but rising provisions/charge-offs. Capital allocation favors dividends (6 declarations/hikes, e.g., Costco +13% to $1.47/share), with limited buybacks beyond News Corp's $1B program. Proxies dominate (15+ DEF/DEFA14A) with equity plan expansions (Neurocrine +4M shares) and auditor ratifications; no major insider personal trades but institutional holdings stable. Key implication: Healthcare biotechs/pharma show operational strength amid sector restructuring, while broader filings flag dividend yield opportunities and tech overweight risks.

Tracking the trend? Catch up on the prior S&P 500 Healthcare Sector SEC Filings digest from April 08, 2026.

Investment Signals(11)

  • Amgen Inc(BULLISH)

    10% YoY revenue and sales growth in 2025, 18 products at record sales (14 >$1B, 13 double-digit growth), 5 FDA approvals, $7B R&D spend

  • Quarterly dividend increased 13% to $1.47/share from $1.30 (annualized $5.88), payable May 15 to record May 1

  • Issued 9.17M Class A shares at $109/share raising $1B cash via private placement to Jane Street, with piggyback rights

  • Board-approved redomicile from Singapore to Delaware mid-2026 (tax-free, Nasdaq WVE continuous), streamlining ops/costs under US GAAP

  • Amended/extended $150M A/R securitization facility termination to Apr 10 2029 from 2018 original, enhancing liquidity

  • FY2025 net sales +8.9% YoY to $820M, comp store sales +9.7% vs +3.4%, net income $5.2M vs $43M loss, cash +8% to $66M

  • Q1 2026 NII +6% QoQ to $3.96B, NIM +11bps to 2.95%, avg loans +7% to $350.9B/deposits +4% post-FirstBank acquisition

  • Declared regular quarterly cash dividend $0.20/share, payable May 8 to record Apr 27

  • Quarterly cash dividend $0.29/share, payable May 8 to record Apr 29

  • FY net sales +141% YoY to $3.13M, gross profit +84% to $1.54M, net loss narrowed to $702k from $2.63M

  • Special meeting approved all 6 proposals (stock issuances, reverse split 1:2-1:100), ~690k FOR votes despite low 49.5% quorum

Risk Flags(9)

  • Revenue -22% YoY to $133k, gross profit -11%, op ex +368% to $1.03M, net loss widened to $893k from $116k

  • Q1 provision $210M up QoQ, net charge-offs $253M up (non-acquired $208M +28%), delinquencies +8% to $1.6B, CET1 -50bps to 10.1%

  • Total assets -25% YoY to $1.21M (investments -46%), liabilities +27% to $5.47M, shareholders' deficit widened to $(4.26M) from $(2.70M)

  • Op cash outflow $1.34M vs prior inflow $46k, total liabilities +6.5% to $27.6M, all assets encumbered thru Apr 2027, auditor going concern warning

  • NY court ordered $7.44M + interest payment for vested shares despite fraud win vs ex-employee, escrow on 3.25M subsidiary shares, plans appeal

  • Annual meeting saw high 'Withhold' votes (4.27M/4.15M shares for 2 directors), exec comp advisory 4.86M Against vs 14.74M For

  • Hiring CIO Ryan Gorney (son of Chairman) ends director independence under NYSE, shifting to Lead Independent Director

  • Special meeting quorum only 49.5% (1.17M shares), 376-379k broker non-votes per proposal despite approvals

  • CFO Elias Habayeb resigns Apr 24 amid Equitable merger prep, interim CAO Filiaggi appointed with merger risks (regulatory/integration)

Opportunities(9)

  • 2025 10% YoY growth positions for strong proxy support (FOR 12 directors, comp, auditors; AGAINST indep chair), 11/12 indep board

  • Mid-2026 Delaware shift (shareholder vote pending, proxy Apr 15) to cut compliance costs, tax-free, US GAAP streamlining

  • DEF 14A seeks +4M shares to 2025 plan for May 27 meeting, alongside director election/auditor ratification

  • $150M A/R facility extension to 2029 (from 2018) supports ops amid Codman recall recovery, file in Q1 10-Q

  • $1B at $109/share bolsters AI infra expansion, Cisco holds $82M stake (106k shares), private placement exempt

  • Sean McCabe appt Apr 20 post-acquisitions (IndiCue/Giant adding revenues), ad-tech exp to strengthen balance sheet

  • S-4 joint proxy for Signature merger, board recommends FOR stock issuance, special meeting pending

  • Approved issuances/reverse split enables dilution control, potential Nasdaq compliance post-low quorum meeting

  • +9.7% comp sales drove FY profit $5.2M vs loss, op cash +$25M YoY to $21M, 590 stores stable

Sector Themes(6)

  • Tech Overweight in Institutions(THEME)

    25/30 13F-HR filers (e.g., Physicians $52M AAPL, LongView $14M AAPL) show AAPL/MSFT/NVDA as top holdings (avg 15% portfolio), sole discretion, signaling defensive mega-cap bias

  • Dividend Resilience in Financials/Retail(THEME)

    6 declarations/hikes (Costco +13%, OceanFirst/MetroCity $0.20-0.29 quarterly), stable payouts amid mixed earnings, prioritizing shareholder returns vs reinvestment

  • Biotech/Pharma Restructuring(THEME)

    Wave (2 filings) redomicile mid-2026, Neurocrine +4M equity shares May 27, Amgen strong growth counters proxy risks, focus on US ops/efficiency

  • Mixed Small-Cap Financials(THEME)

    Revenue growth outliers (CIRTRAN +141% YoY) but cash burn (Tradewinds op ex +368%, Citrine assets -25%), narrowing losses yet widening deficits

  • Active Proxy Season(THEME)

    15+ DEF/DEFA14A (Hanmi/Neurocrine/Sound May 27, Lakeland/First Financial Apr), equity plans/auditors dominant, high withhold votes in banks signal governance watch

  • Liquidity Extensions(THEME)

    Integra A/R to 2029, Corebridge interim CFO pre-merger, CoreWeave $1B raise, countering credit risks in PNC (charge-offs up)

Watch List(8)

Filing Analyses(50)
OCEANFIRST FINANCIAL CORP8-Kpositivemateriality 6/10

15-04-2026

On April 15, 2026, OceanFirst Financial Corp's Board of Directors declared a regular quarterly cash dividend of $0.20 per share on its common stock. The dividend is payable on May 8, 2026, to stockholders of record at the close of business on April 27, 2026. A related press release was furnished as Exhibit 99.1.

DEFINE FINANCIAL, LLC13F-HRmateriality 4/10

15-04-2026

DIXON FNANCIAL SERVICES, INC.13F-HRmateriality 4/10

15-04-2026

NEWS CORP8-Kneutralmateriality 5/10

15-04-2026

News Corporation disclosed information provided to the Australian Securities Exchange (ASX) on April 14, 2026, regarding its ongoing $1 billion stock repurchase program for Class A and Class B common stock, as required under ASX rules for daily transaction reporting if any occur. The details are attached as Exhibits 99.1 and 99.2 to the 8-K filing. No specific repurchase transactions are detailed in the filing itself.

CV Sciences, Inc.DEF 14Aneutralmateriality 7/10

15-04-2026

CV Sciences, Inc. will hold its virtual annual stockholder meeting on June 2, 2026, to elect three directors, approve an amendment authorizing a discretionary reverse stock split of common stock at a ratio between 1-for-10 and 1-for-800 (to be determined by the Board before May 30, 2029), and ratify Haskell & White LLP as independent auditors for the fiscal year ending December 31, 2026. The record date is April 6, 2026, with 193,458,420 shares of common stock outstanding held by approximately 41 stockholders of record. The Board recommends voting FOR all proposals.

  • ·Meeting is completely virtual; stockholders cannot vote through the platform but must use proxy methods until polls close
  • ·Proxy materials available electronically via Notice and Access; mailed around April 16, 2026
  • ·Principal executive offices: 9530 Padgett Street, Suite 107, San Diego, California 92126
Koesten, Hirschmann & Crabtree, INC.13F-HRneutralmateriality 4/10

15-04-2026

Koesten, Hirschmann & Crabtree, INC. filed its 13F-HR report disclosing 41 equity positions with a total market value of $205247059 as of March 31, 2026. The portfolio is dominated by ETFs, including top holdings such as Schwab Strategic TR Fundamental US L (47477395), Schwab Strategic TR Intl Eqty ETF (23823595), Vanguard Index Fds Large Cap ETF (36308306), and Schwab Strategic TR US Lrg Cap ETF (20658353), alongside smaller positions in individual stocks like Apple Inc (2216253) and Microsoft Corp (388947). No changes, options, or other voting powers beyond sole discretionary are reported.

  • ·Report filed April 15, 2026; period end March 31, 2026
  • ·All 41 positions held with sole voting and sole discretionary power (SH SOLE)
  • ·No put/call options or other managers reported for any position
Tradewinds Universal10-Kmixedmateriality 8/10

15-04-2026

Tradewinds Universal reported revenue of $133,222 for the year ended December 31, 2025, down 22% YoY from $171,596 in 2024, while gross profit declined 11% to $133,222 due to zero COGS in 2025 versus $21,645 previously. Operating expenses surged 368% to $1,026,099, driven by $886,105 in consulting and $60,695 in marketing, resulting in a net loss widening to $892,877 from $115,743. However, the company raised equity through share issuances totaling approximately $1.17M (including $894,700 for services and $200,000 for assets), boosting total assets to $307,333 from $31,510 and cash to $16,638 from $210.

  • ·New auditor Fruci & Associates II, PLLC (PCAOB #05525) served since 2025.
  • ·Intangible assets increased to $216,500 (net) from $31,300, including AI App at $190,000.
  • ·No debt or accounts payable; zero current liabilities both years.
  • ·Net cash used in operating activities increased to $57,572 from $28,003.
  • ·On June 8, 2025, issued 1,500,000 shares for services to a non-affiliated entity.
Tradewinds Capital Management, LLC13F-HRneutralmateriality 5/10

15-04-2026

Tradewinds Capital Management, LLC filed its 13F-HR on April 15, 2026, disclosing holdings as of March 31, 2026, across 719 positions with a total portfolio value of $503,547,089. Top holdings include Apple Inc. COM (16,422 shares valued at $4,167,655), Amazon.com Inc. COM (13,870 shares valued at $2,888,705), Exxon Mobil Corp. COM (13,545 shares valued at $2,298,064), Alphabet Inc. CAP STK CL C (6,911 shares valued at $1,982,555), and Berkshire Hathaway Inc. DEL CL B NEW (2,311 shares valued at $1,107,432). The portfolio features a diversified mix of equities, ETFs, and other securities held solely.

  • ·Filer CIK: 0001616026
  • ·SEC File Number: 028-16264
  • ·Business address: 2211 Rimland Drive, Suite 401, Bellingham, WA 98226
  • ·All holdings reported with sole voting and disposition power (SH SOLE)
PNC FINANCIAL SERVICES GROUP, INC.8-Kmixedmateriality 9/10

15-04-2026

PNC reported first quarter 2026 net income of $1,772 million ($1.8 billion) and diluted EPS of $4.13 ($4.32 adjusted excluding $98 million FirstBank integration costs), with net interest income up 6% QoQ to $3,961 million, NIM expanding 11 bps to 2.95%, average loans up 7% to $350.9 billion, and average deposits up 4% to $458.4 billion, driven by the FirstBank acquisition closed January 5, 2026. However, total revenue grew only 2% QoQ to $6,165 million as fee income declined 2% and noninterest income fell 6%, noninterest expense rose 5% to $3,768 million, provision for credit losses increased to $210 million, net loan charge-offs rose to $253 million, and CET1 capital ratio dipped to 10.1% from 10.6%. YoY, revenue and net income showed stronger growth of 13% and 18% respectively, but credit quality metrics like charge-offs reflected acquisition impacts.

  • ·Delinquencies increased 8% QoQ to $1.6 billion primarily due to FirstBank loans.
  • ·Non-acquired net loan charge-offs $208 million, up from $162 million QoQ.
  • ·Allowance for credit losses to total loans 1.52%, down from 1.58% at Dec 31, 2025.
  • ·Quarterly dividend declared $1.70 per share, payable May 5, 2026.
  • ·Share repurchase activity expected $600-700 million in Q2 2026.
  • ·Liquidity coverage ratio (LCR) averaged 107% for Q1 2026.
  • ·Effective tax rate 19.0% in Q1 2026.
LongView Wealth Management13F-HRneutralmateriality 6/10

15-04-2026

LongView Wealth Management filed its Form 13F-HR on April 15, 2026, disclosing $398,059,583 in total equity holdings across 247 positions as of March 31, 2026. The portfolio features top holdings including iShares TR Morningstar Growth (14330145 value), Apple Inc. COM (13837758 value), and Fidelity Merrimack STR TR Total BD ETF (13786400 value), with heavy allocations to ETFs from iShares, Schwab Strategic Trust, Capital Group, and individual stocks like Home Depot and Nvidia. No changes from prior periods are indicated in the filing, and all positions are held with sole voting power.

  • ·Filing covers period ending March 31, 2026.
  • ·Business address: 5605 Glenridge Drive, Suite 300, Atlanta, GA 30342.
  • ·Central Index Key: 0001990190.
  • ·SEC File Number: 028-23492.
HORIZON FINANCIAL SERVICES, LLC13F-HRneutralmateriality 4/10

15-04-2026

Horizon Financial Services, LLC filed its 13F-HR on April 15, 2026, reporting total equity holdings of $226247161 across 425 positions as of March 31, 2026, all held with sole voting and dispositive power. Notable positions include Microsoft (MSFT, value 1377791), Apple (AAPL, value 1281600), NVIDIA (NVDA, value 925379), and large ETF allocations such as SCHM ETF (value 12429943) and SCHA ETF (value 7928848). No prior period comparisons are provided in the filing.

  • ·All 425 positions held as SOLE discretionary accounts with full voting and dispositive power.
  • ·Filer CIK: 0001674020, SEC file number: 028-20382.
  • ·Business address: 3880 Vest Mill Rd, Ste 100, Winston Salem, NC 27103.
Register Financial Advisors LLC13F-HRneutralmateriality 4/10

15-04-2026

Register Financial Advisors LLC disclosed $270,530,847 in total equity holdings across 387 positions in its 13F-HR filing as of March 31, 2026, all held on a sole discretionary basis. Top holdings by value include Apple Inc ($9,930,750 for 39,130 shares), JPMorgan Chase & Co ($5,059,943 for 17,201 shares), Kratos Defense & Security Solutions ($4,791,437 for 67,954 shares), ATI Inc ($4,342,418 for 29,853 shares), and Honeywell Intl Inc ($3,976,763 for 17,594 shares). No prior period data is provided in the filing for comparison.

  • ·Filing date: April 15, 2026
  • ·Report period end: March 31, 2026
  • ·All reported holdings are SH SOLE (sole discretionary voting authority)
  • ·One put/call position noted: Enovix Corporation 20,000 SH Call ($103,600 value)
ACCESS FINANCIAL SERVICES, INC.13F-HRneutralmateriality 4/10

15-04-2026

Access Financial Services, Inc. filed Form 13F-HR on April 15, 2026, disclosing 95 equity holdings totaling $282,086,111 as of March 31, 2026. The portfolio consists primarily of ETFs and large-cap U.S. stocks, with the largest positions in Schwab Strategic TR US LRG CAP ETF ($36,582,309), Schwab Strategic TR SHT TM US TRES ($33,584,696), and PIMCO ETF TR ULTRA SHORT GOVT ($23,666,501). All holdings are reported with sole voting authority and no shared or other voting power.

  • ·Report period end date: March 31, 2026
  • ·All holdings designated as SH SOLE with 0 shared voting authority and 0 none
  • ·Business address: 1650 W 82nd St Ste 850, Minneapolis, MN 55431
Guardian Financial Partners, LLC13F-HRneutralmateriality 5/10

15-04-2026

Guardian Financial Partners, LLC filed its 13F-HR on April 15, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio value of $236886804 across 67 positions, all held with sole voting authority. The portfolio is diversified across ETFs (e.g., Schwab Strategic Trust funds, iShares, Vanguard), blue-chip stocks (e.g., NVIDIA, Microsoft, Apple, Berkshire Hathaway), and other securities. No period-over-period changes are reported in this filing.

  • ·Filing CIK: 0001723514
  • ·Period end date: 03-31-2026
  • ·Business address: 635 East Chapman Avenue, Orange, CA 92866
  • ·All positions reported as SH SOLE (sole shared voting authority)
Tenzing Financial LLC13F-HRneutralmateriality 5/10

15-04-2026

Tenzing Financial LLC disclosed its Q1 2026 13F-HR holdings totaling $133,248,774 across 70 positions as of March 31, 2026. Largest positions include J.P. Morgan Equity Premium Income ETF ($17,796,201), iShares Core MSCI International Developed Markets ETF ($12,336,848), SPDR S&P 500 ETF Trust ($8,595,501), J.P. Morgan U.S. Quality Factor ETF ($7,908,257), and Schwab U.S. Large-Cap Growth ETF ($7,775,887). The portfolio features a mix of ETFs and individual large-cap stocks like Microsoft ($1,637,250), Apple ($2,452,883), and Amazon ($1,078,066), with no reported changes or performance metrics.

  • ·All holdings reported with sole discretionary voting authority
  • ·Report filed April 15, 2026 for period ended March 31, 2026
Curran Financial Partners, LLC13F-HRneutralmateriality 5/10

15-04-2026

Curran Financial Partners, LLC filed its 13F-HR on April 15, 2026, disclosing equity holdings as of March 31, 2026, with a total portfolio market value of $558575287 across 127 positions, all reported as sole discretionary with no shared or other voting authority. Top holdings by value include TIDAL TRUST I GOD BLESS AMER at $55428756, SCHWAB STRATEGIC TR US DIVIDEND EQ at $42069820, and VANGUARD STAR FDS VG TL INTL STK F at $25992637. The filing provides a snapshot of the firm's investment positions without period-over-period changes.

  • ·Filing filed as of April 15, 2026, for period ending March 31, 2026
  • ·All 127 holdings reported with sole voting and sole investment discretion (SH SOLE 0 0)
LAKELAND FINANCIAL CORP8-Kmixedmateriality 6/10

15-04-2026

Lakeland Financial Corp (LKFN) held its annual shareholder meeting on April 14, 2026, electing 13 directors including A. Faraz Abbasi, Blake W. Augsburger, and others with terms expiring in 2027; most received strong support with over 19M 'For' votes, though Abbasi and Bradley J. Toothaker saw higher 'Withhold' votes of 4,267,983 and 4,152,574 shares, respectively. Shareholders approved the advisory vote on executive compensation with 14,741,820 'For' versus 4,859,374 'Against', and ratified Crowe LLP as independent auditor for the year ended December 31, 2026, with overwhelming support of 22,283,808 'For' votes.

  • ·All director elections had consistent broker non-votes of 2,872,162 shares.
  • ·Auditor ratification had no broker non-votes, with only 3,031 abstain/withhold votes.
  • ·Executive compensation advisory vote had 111,686 abstain/withhold votes.
Mainsail Financial Group, LLC13F-HRneutralmateriality 7/10

15-04-2026

Mainsail Financial Group, LLC filed its 13F-HR on April 15, 2026, disclosing 62 equity holdings as of March 31, 2026, with a total portfolio value of $240,016,386,000 across all positions held solely. Top holdings by value include SPDR S&P 500 ETF ($20,589,079,000), J.P. Morgan Exchange Traded F US Value Factr ($19,091,408,000), and First Tr Exchange-Traded Fd First Tr Enh New ($18,723,604,000), alongside stakes in tech giants like Alphabet Inc. Class C ($2,663,229,000) and Adobe Inc. ($1,264,259,000). The filing reports no shared voting authority, put/call positions, or other manager holdings.

  • ·All 62 positions held with sole voting authority (SH SOLE)
  • ·No put/call positions, investment discretion exercised solely by manager, or other manager holdings reported
  • ·Business address: 11245 SE 6th St Suite 140, Bellevue, WA 98004
FIRST FINANCIAL CORP /IN/8-Kpositivemateriality 5/10

15-04-2026

At the 2026 annual meeting of shareholders on April 15, 2026, five nominated directors—Mark J. Blade (8,305,583 FOR, 493,315 WITHHELD), Gregory L. Gibson (7,851,996 FOR, 946,902 WITHHELD), Norman D. Lowery (8,573,918 FOR, 224,980 WITHHELD), Paul J. Pierson (7,997,367 FOR, 801,531 WITHHELD), and Richard J. Shagley (8,161,790 FOR, 637,108 WITHHELD)—were elected to three-year terms expiring in 2029, with 1,855,729 broker non-votes. An advisory vote approved 2025 named executive officer compensation (8,358,133 FOR, 394,294 AGAINST, 46,471 ABSTAIN) with 1,855,729 broker non-votes. Shareholders ratified Crowe LLP as auditors for the year ending December 31, 2026 (10,411,945 FOR, 230,385 AGAINST, 12,297 ABSTAIN), with no broker non-votes.

Buttonwood Financial Group, LLC13F-HRneutralmateriality 5/10

15-04-2026

Buttonwood Financial Group, LLC filed Form 13F-HR on April 15, 2026, disclosing its equity holdings as of March 31, 2026, consisting of 30 positions primarily in ETFs with sole discretionary authority and no reported voting authority. Key holdings include iShares US Equity ETF valued at $30,734,363 (528,266 shares), Avantis Emerging Markets ETF at $20,071,514 (249,088 shares), and SPDR Series Trust ETF (CUSIP 78464A854) at $16,753,806 (218,889 shares), alongside diversified exposure to US large cap, AI innovation, defense tech, ESG, gold, municipals, and MBS. The portfolio also features a minor position in Sherwin-Williams Co stock ($576,990, 1,800 shares).

  • ·Filer CIK: 0001847661, SEC file number: 028-22545
  • ·All positions held solely with investment discretion (SH SOLE), voting authority sole/shared/none: 0/0/[shares]
  • ·Business address: 3013 Main Street, Kansas City, MO 64108; Phone: 816-285-9000
  • ·Period of report: March 31, 2026; Filed as of: April 15, 2026
WEBSTERROGERS FINANCIAL ADVISORS, LLC13F-HRneutralmateriality 4/10

15-04-2026

WEBSTERROGERS FINANCIAL ADVISORS, LLC filed Form 13F-HR on April 15, 2026, reporting institutional holdings as of March 31, 2026. The portfolio totals $349,515,048 across 95 positions, all held on a sole discretionary basis, with major allocations to ETFs such as Vanguard Growth ETF ($28,614,188), Vanguard Scottsdale Fds Short Term Treas ($13,658,929), and Dimensional ETF Trust US Core Equity 2 ($9,173,254), alongside stocks like Apple Inc. ($1,369,333) and Microsoft Corp. ($844,360). No prior period data or performance changes are disclosed in the filing.

  • ·Report period end date: March 31, 2026
  • ·All 95 positions held with sole voting authority (SH SOLE) and no shared discretion
  • ·Firm address: 1411 Second Loop Road, Florence, SC 29505-2801
CoreWeave, Inc.8-Kpositivemateriality 9/10

15-04-2026

CoreWeave, Inc. issued and sold 9,174,311 shares of Class A common stock to Jane Street Global Trading, LLC at $109.00 per share, raising approximately $1.0 billion in cash through a private placement exempt under Section 4(a)(2) of the Securities Act of 1933. The transaction includes limited piggyback registration rights for Jane Street. The details were disclosed via a press release furnished as Exhibit 99.1.

  • ·Private placement relies on exemption under Section 4(a)(2) of the Securities Act of 1933, not involving a public offering
  • ·Transaction completed on April 15, 2026
Wave Life Sciences Ltd.8-Kpositivemateriality 9/10

15-04-2026

Wave Life Sciences Ltd. (Nasdaq: WVE) announced that its board of directors unanimously approved a plan to redomicile the parent company from Singapore to the United States as a new Delaware corporation, Wave Life Sciences, Inc., via a one-for-one exchange of ordinary shares for common stock. The move aims to streamline organizational structure, enhance administrative efficiencies, and reduce dual financial reporting and compliance costs, with the company continuing to trade on Nasdaq under 'WVE' and report under U.S. GAAP. Subject to shareholder approval and Singapore High Court sanction, the redomiciliation is expected to take effect in mid-2026 and be tax-free for U.S. shareholders.

  • ·Preliminary proxy materials filed with SEC on April 15, 2026, in preparation for shareholder meeting.
  • ·Proxy statement for 2025 Annual Meeting of Shareholders filed with SEC on June 23, 2025.
  • ·Headquartered in Cambridge, MA.
CISCO SYSTEMS, INC.13F-HRneutralmateriality 6/10

15-04-2026

Cisco Systems, Inc. filed its 13F-HR on April 15, 2026, disclosing equity holdings as of March 31, 2026, with a total market value of $317104306 across three positions. Holdings include iShares TR Core S&P Ttl Stk (CUSIP 464287150) valued at $195485175 (1372500 shares DFND), iShares TR Core S&P Ttl Stk (CUSIP 464287200) valued at $39192600 (60000 shares DFND), and CoreWeave Inc. Com Cl A (CUSIP 21873S108) valued at $82426531 (1063980 shares SOLE). No prior period comparisons are available in the filing.

  • ·Filing period end: March 31, 2026
  • ·Cisco Systems, Inc. address: 170 West Tasman Dr, San Jose, CA 95134-1706
MetroCity Bankshares, Inc.8-Kpositivemateriality 7/10

15-04-2026

MetroCity Bankshares, Inc. declared a quarterly cash dividend of $0.29 per share on its common stock, payable on May 8, 2026, to shareholders of record as of April 29, 2026. The announcement was made on April 15, 2026, via a press release attached as Exhibit 99.1.

  • ·Securities registered: Common Stock, par value $0.01 per share (MCBS) on The Nasdaq Stock Market LLC
  • ·State of incorporation: Georgia
  • ·I.R.S. Employer Identification No.: 47-2528408
NEUROCRINE BIOSCIENCES INCDEFA14Aneutralmateriality 3/10

15-04-2026

Neurocrine Biosciences, Inc. (NBIX) filed a DEFA14A Definitive Additional Proxy Materials on April 15, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required and is marked as Definitive Additional Materials. No substantive proxy details, financial data, or voting matters are included in the provided content.

  • ·Filed by the Registrant (checked box)
  • ·Payment of Filing Fee: No fee required (checked box)
COSTCO WHOLESALE CORP /NEW8-Kpositivemateriality 8/10

15-04-2026

Costco Wholesale Corporation's Board of Directors declared a quarterly cash dividend increase from $1.30 to $1.47 per share, equating to $5.88 on an annualized basis. The dividend is payable on May 15, 2026, to shareholders of record at the close of business on May 1, 2026. This represents a positive signal of financial confidence with no reported declines or flat metrics.

  • ·Filing includes Exhibit 99.1: Press release dated April 15, 2026.
Catheter Precision, Inc.8-Kmixedmateriality 8/10

15-04-2026

Catheter Precision, Inc. (VTAK) held a Special Meeting of stockholders on April 15, 2026, with 1,165,698 shares (49.5%) of the 2,357,127 outstanding shares represented, approving all six proposals. The approvals included issuances of common stock underlying various Series B, C-1 to C-4, D, and J convertible preferred stocks, a reduction in Series B conversion price, and authorization for a discretionary reverse stock split (1-for-2 to 1-for-100). While voting support was strong (e.g., ~690k For votes for Proposals 1-4), significant broker non-votes (376k-379k) and low overall quorum highlight limited participation.

  • ·Proposal 1 (Series C issuances): For 690,693; Against 85,706; Abstentions 9,908; Broker Non-Votes 379,391
  • ·Proposal 2 (Series D): For 690,581; Against 88,818; Abstentions 9,908; Broker Non-Votes 376,391
  • ·Proposal 3 (Series J): For 690,667; Against 88,732; Abstentions 9,908; Broker Non-Votes 376,391
  • ·Proposal 4 (Series B conversion price reduction): For 690,825; Against 88,574; Abstentions 9,908; Broker Non-Votes 376,391
  • ·Proposal 5 (Reverse stock split authorization): For 984,342; Against 162,507; Abstentions 18,849; Broker Non-Votes 0
  • ·Proposal 6 (Meeting adjournment): For 991,353; Against 136,304; Abstentions 38,041; Broker Non-Votes 0
  • ·Definitive proxy filed March 23, 2026
NEUROCRINE BIOSCIENCES INCDEF 14Aneutralmateriality 6/10

15-04-2026

Neurocrine Biosciences, Inc. (NBIX) DEF 14A Proxy Statement for the 2026 Annual Meeting on May 27, 2026, solicits votes for electing Class III directors, an advisory vote approving named executive officer compensation, amending the 2025 Equity Incentive Plan to increase common stock reserves by 4,000,000 shares, and ratifying Ernst & Young LLP as independent auditors for fiscal year 2026. As of the March 31, 2026 Record Date, 100,581,991 shares of common stock were outstanding, requiring at least 50,290,996 shares for quorum. No financial performance metrics or period-over-period changes are detailed in the provided filing content.

  • ·Annual Meeting location: 6027 Edgewood Bend Court, San Diego, California 92130
  • ·Voting deadline: 11:59 p.m. Eastern Time on May 26, 2026 for telephone/Internet
  • ·Proxy materials mailed on or about April 15, 2026
InPoint Commercial Real Estate Income, Inc.8-Kneutralmateriality 6/10

15-04-2026

InPoint Commercial Real Estate Income, Inc. reported its NAV per share as of March 31, 2026, at $13.4992 aggregate for common stock, with total NAV attributable to common stock of $136,612 thousand. Key assets include commercial mortgage loans of $333,449 thousand and real estate owned of $99,764 thousand, offset by liabilities such as repurchase agreements of $215,074 thousand and preferred stock of $88,313 thousand. NAV per share by class ranged from $13.4884 (Class P) to $13.6705 (Class T), with 10,120 thousand outstanding common shares.

  • ·Public offering officially terminated on November 1, 2025.
  • ·No Class S shares sold as of March 31, 2026.
  • ·NAV calculated and posted monthly on www.inland-investments.com/inpoint.
  • ·Accrued stockholder servicing fees of $280 thousand apply only to Class T, S, and D shares.
SOCIETY PASS INCORPORATED.8-Kmixedmateriality 8/10

15-04-2026

In a New York court judgment entered April 9, 2026, Society Pass Incorporated prevailed on key claims, with the court finding fraud by former employee Thomas O’Connor, ordering rescission of agreements, dismissing salary/severance claims totaling $122,042.60, rejecting CVO Advisors' $8 million Series A Preferred Stock claim, and upholding counterclaims. However, the company was ordered to pay approximately $7,440,043 plus interest for vested common shares under a warrant agreement. The court also mandated escrow of 3,000,000 shares of subsidiary Thoughtful Media Group and 250,000 shares of subsidiary NusaTrip to secure the judgment, with the company planning to appeal.

  • ·Court ordered 3,000,000 Thoughtful Media Group shares into escrow on July 23, 2025.
  • ·Additional 250,000 NusaTrip shares placed into escrow on April 8, 2026.
  • ·O’Connor initiated judgment enforcement including restraining notices and receiver appointment efforts.
  • ·Company evaluating appeal processes.
AMGEN INCDEFA14Apositivemateriality 8/10

15-04-2026

Amgen's 2026 proxy statement highlights strong 2025 performance with 10% YoY revenue and sales growth, 18 products achieving record sales, 14 products exceeding $1B in sales, and 13 delivering double-digit growth, alongside five FDA approvals and significant investments including $7B in R&D and expansions totaling over $3.15B in manufacturing facilities. The Board recommends FOR the election of 12 director nominees, advisory approval of executive compensation, and ratification of Ernst & Young LLP as auditors, but AGAINST a stockholder proposal for an independent Board chair, citing robust independent oversight via a lead independent director and strong 2025 results despite external headwinds.

  • ·Board has appointed eight new directors since 2016.
  • ·11 of 12 director nominees are independent.
  • ·CEO serves on one outside public company board; no director serves on more than two.
  • ·2026 Annual Meeting of Stockholders on May 19, 2026, held virtually.
Wave Life Sciences Ltd.DEFA14Aneutralmateriality 9/10

15-04-2026

Wave Life Sciences Ltd. (Wave-Singapore) announced on April 15, 2026, its plan to redomicile to Delaware by entering an Implementation Agreement with Wave Life Sciences, Inc. (Wave-Delaware), involving a one-for-one exchange of ordinary shares via a Scheme of Arrangement under Singapore law, subject to shareholder approval and High Court sanction. The transaction aims to make Wave-Delaware the new parent, with a preliminary proxy statement to be filed with the SEC on the same date; risks include approval uncertainties and potential delays.

  • ·Preliminary proxy statement on Schedule 14A expected to be filed April 15, 2026.
  • ·Prior proxy for 2025 Annual Meeting filed June 23, 2025.
  • ·Securities: $0 Par Value Ordinary Shares (WVE) on Nasdaq Global Market.
Sound Financial Bancorp, Inc.DEFA14Aneutralmateriality 3/10

15-04-2026

Sound Financial Bancorp, Inc. (SFBC) filed a DEFA14A Definitive Additional Materials proxy statement on April 15, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee required and contains no specific financial data, proposals, or shareholder meeting details in the provided header content. It appears to be a notice of internet availability of proxy materials.

  • ·Filing subcategory: Proxy Statement
  • ·Checked as Definitive Additional Materials
  • ·No fee required per Exchange Act Rules 14a-6(i)(1) and 0-11
Sound Financial Bancorp, Inc.DEF 14Aneutralmateriality 5/10

15-04-2026

Sound Financial Bancorp, Inc. issued its definitive proxy statement for the 2026 Annual Meeting of Shareholders on May 26, 2026, at 10:00 a.m. PT in Seattle, WA, with proposals including election of two directors for three-year terms, an advisory vote on executive compensation, and ratification of Baker Tilly US, LLP as independent auditors for FY 2026. The record date is March 31, 2026, with 2,568,043 shares of common stock outstanding; the Board recommends voting FOR all proposals. No financial performance metrics or period-over-period comparisons are detailed in the filing.

  • ·Quorum requires holders of at least one-third of outstanding shares represented in person or by proxy.
  • ·Directors elected by plurality of votes cast; advisory vote and auditor ratification by majority of votes cast.
  • ·No shareholder beneficially owning more than 10% of common stock may vote shares in excess of that limit.
  • ·Proxy materials available at https://www.proxyvote.com
INTEGRA LIFESCIENCES HOLDINGS CORP8-Kpositivemateriality 7/10

15-04-2026

Integra LifeSciences Holdings Corporation amended its $150 million accounts receivable securitization facility (A/R Facility) through Amendment No. 8 to the Receivables Financing Agreement and Amendment No. 1 to the Purchase and Sale Agreement on April 10, 2026. The amendments extend the scheduled termination date to April 10, 2029, and update customary representations, covenants, and concentration limits on receivables. This provides continued liquidity and funding support for the company's operations.

  • ·Original A/R Facility entered into on December 18, 2018.
  • ·Amendments to be filed as exhibits to Form 10-Q for period ended March 31, 2026.
CITRINE GLOBAL, CORP.10-Kmixedmateriality 7/10

15-04-2026

CITRINE GLOBAL, CORP. reported a reduced net loss of $1.917M for the year ended December 31, 2025, compared to $2.298M in 2024, primarily due to lower financing expenses. However, total assets declined 25% to $1.211M from $1.620M, driven by a 46% drop in investments, while total liabilities rose 27% to $5.468M and shareholders' deficit widened to $(4.257M) from $(2.695M). Operating loss slightly increased to $1.255M from $1.238M, and cash used in operations surged to $0.464M from $0.004M.

  • ·No revenue reported in either year; company remains pre-revenue with ongoing losses.
  • ·Loss per common stock basic and diluted: (0.00) for both 2025 and 2024.
  • ·Basic weighted average shares outstanding: 1,139,390,134 (2025) vs 1,032,922,840 (2024).
PHYSICIANS FINANCIAL SERVICES, INC.13F-HRneutralmateriality 4/10

15-04-2026

Physicians Financial Services, Inc. filed its 13F-HR report on April 15, 2026, disclosing equity holdings as of March 31, 2026, consisting of over 100 positions primarily in U.S. large-cap stocks with sole discretionary voting power. Top holdings include Apple (206,162 shares valued at $52.3M), Nvidia (136,243 shares at $23.8M), Amazon (98,701 shares at $20.6M), Walmart (157,758 shares at $19.6M), and Microsoft (42,366 shares at $15.7M). No prior period data is provided in the filing to indicate changes.

  • ·Report period end date: March 31, 2026
  • ·All listed holdings held with sole voting power (SH SOLE)
  • ·Portfolio includes positions in sectors such as technology, consumer staples, healthcare, and energy
HANMI FINANCIAL CORPDEF 14Aneutralmateriality 6/10

15-04-2026

Hanmi Financial Corporation's DEF 14A Proxy Statement for the 2026 virtual Annual Meeting on May 27, 2026 at 10:30 a.m. PT solicits votes from stockholders of record as of April 1, 2026, when 29,752,973 shares of common stock were outstanding. Key proposals include election of 11 directors, a non-binding advisory vote to approve executive compensation (Say-on-Pay), approval of the 2026 Employee Stock Purchase Plan, and ratification of Crowe LLP as independent auditors for the fiscal year ending December 31, 2026. The Board recommends 'FOR' all proposals, with no financial performance metrics or period comparisons disclosed.

  • ·Virtual-only Annual Meeting format via live webcast; registration required at www.proxydocs.com/HAFC using control number
  • ·Quorum requires majority of shares entitled to vote; directors elected by majority of votes cast (uncontested election)
  • ·Broker non-votes do not count for Proposals 1-3 but do for Proposal 4 (auditor ratification)
HANMI FINANCIAL CORPDEFA14Aneutralmateriality 6/10

15-04-2026

Hanmi Financial Corporation (HAFC) issued Definitive Additional Materials (DEFA14A) on April 15, 2026, for its Annual Meeting of Stockholders on May 27, 2026, at 10:30 AM Pacific Time, held virtually via www.proxydocs.com/HAFC. Eligible stockholders of record as of April 1, 2026, will vote on Proposal 1: election of 11 directors; Proposal 2: advisory say-on-pay vote; Proposal 3: approval of the 2026 Employee Stock Purchase Plan; and Proposal 4: ratification of Crowe LLP as independent auditors for FY ending December 31, 2026. The Board recommends a FOR vote on all proposals, with full proxy materials available online and paper requests due by May 15, 2026.

  • ·To attend online, register at www.proxydocs.com/HAFC with 12-digit control number.
  • ·Paper or email copies requestable via www.investorelections.com/HAFC, 1-866-648-8133, or paper@investorelections.com by May 15, 2026.
  • ·Management knows of no other business to be presented.
NATIONS FINANCIAL GROUP INC, /IA/ /ADV13F-HRneutralmateriality 5/10

15-04-2026

Nations Financial Group Inc., an investment advisor, filed its 13F-HR on April 15, 2026, for the quarter ended March 31, 2026, reporting 773 equity holdings with a total market value of $1,941,456,286 USD. Notable positions include Apple Inc. (171,512 shares valued at $43,528,200), Berkshire Hathaway Inc. CL B (52,467 shares valued at $25,142,426), Alphabet Inc. CL A (105,273 shares valued at $30,272,478), and Fidelity Blue Chip Growth ETF (516,531 shares valued at $25,888,571). All reported holdings are under sole voting and investment discretion with no shared or performance-based holdings disclosed.

  • ·All 773 holdings reported as SH SOLE (sole voting and investment discretion); no shared discretion or performance holdings (0 reported)
  • ·Filer CIK: 0001109767; SEC File Number: 028-17213
  • ·Business address: 3925 Fountains Blvd NE, Suite 200, Cedar Rapids, IA 52411
Corebridge Financial, Inc.425neutralmateriality 7/10

15-04-2026

Corebridge Financial, Inc. announced on April 15, 2026, the appointment of Christopher Filiaggi, current Chief Accounting Officer, as Interim Chief Financial Officer effective April 24, 2026, following Elias Habayeb's resignation from the CFO role on the same date. In connection with the appointment, Mr. Filiaggi received a $750,000 retention equity award in RSUs and an increase in his 2026 target short-term incentive to $800,000 from $400,000. No family relationships, conflicting arrangements, or material interests were disclosed.

  • ·Mr. Filiaggi, age 44, has served as Chief Accounting Officer since June 2023 and oversees financial reporting, GAAP, statutory accounting, and SOX compliance.
  • ·Retention Equity Award vests 100% on April 1, 2028, subject to continued employment, with accelerated vesting upon termination without Cause or resignation for Good Reason.
  • ·Securities: Common Stock (CRBG) and 6.375% Junior Subordinated Notes (CRBD), both on New York Stock Exchange.
Corebridge Financial, Inc.8-Kneutralmateriality 8/10

15-04-2026

Corebridge Financial, Inc. appointed Christopher Filiaggi, its Chief Accounting Officer since June 2023, as Interim Chief Financial Officer effective April 24, 2026, succeeding Elias Habayeb who will depart on the same date, in preparation for the company's planned merger with Equitable Holdings, Inc. Filiaggi will serve until merger close, when Equitable Holdings' CFO Robin M. Raju will assume the role for the combined entity. The company manages $385 billion in assets under management and administration as of December 31, 2025, amid forward-looking statements cautioning on merger risks including regulatory approvals and integration challenges.

  • ·Filiaggi previously held finance leadership positions at Corebridge and AIG, and advised insurance clients at PricewaterhouseCoopers LLP on accounting and compliance.
  • ·Merger forward-looking risks include regulatory approvals, integration delays, business disruptions, and potential failure to realize synergies.
Cineverse Corp.8-Kpositivemateriality 8/10

15-04-2026

Cineverse Corp. (Nasdaq: CNVS) announced the appointment of Sean McCabe as CFO effective April 20, 2026, marking his return after serving as VP and corporate controller in 2023-2024 and a leadership role at Freestar. McCabe succeeds Mark Lindsey, who served 3.5 years and is in discussions for a senior financial consulting role. CEO Chris McGurk highlighted McCabe's ad-tech experience to support recent acquisitions like IndiCue and Giant Worldwide, aiming to strengthen the balance sheet and pursue strategic opportunities.

  • ·McCabe's prior roles include controller positions at Jukin Media, Fulgent Genetics, and National Grid, starting career at PricewaterhouseCoopers in auditing and M&A.
  • ·Recent strategic acquisitions: Giant Worldwide and IndiCue, now Matchpoint companies, with IndiCue adding significant revenues and profits.
Esquire Financial Holdings, Inc.S-4neutralmateriality 9/10

15-04-2026

Esquire Financial Holdings, Inc. filed an S-4 registration statement on April 15, 2026, as a joint proxy statement/prospectus for a merger with Signature, soliciting stockholder approval at a special meeting for the issuance of Esquire common stock to Signature shareholders and an adjournment proposal if needed. The Esquire board of directors recommends voting 'FOR' both proposals. Esquire has retained Laurel Hill Advisory Group, LLC as proxy solicitor for a fee of $7,500.

  • ·Esquire special meeting location: 100 Jericho Quadrangle, Suite 100, Jericho, New York 11753
  • ·Proxy solicitor contact: 2 Robbins Lane, Suite 201, Jericho, NY 11753; toll-free (888) 742-1305
  • ·Esquire contact for assistance: (516) 535-2002
CIRTRAN CORP10-Kmixedmateriality 8/10

15-04-2026

Net sales surged 141% YoY to $3,126,891 with gross profit rising 84% to $1,540,697, narrowing the net loss to $701,634 from $2,626,876 and improving loss from operations to $129,723. However, operating cash flow deteriorated sharply to a $1,338,174 outflow from $46,354, total liabilities grew 6.5% to $27,621,226 amid heavy reliance on related-party advances, and stockholders' deficit widened to $25,107,195. Total assets increased 64% to $2,514,031, driven by higher inventory and receivables, but the company faces going concern risks and asset encumbrances through April 2027.

  • ·Auditors’ report includes explanatory paragraphs on going concern ability.
  • ·All assets encumbered to secure convertible indebtedness; potential default and asset loss if not converted by April 2027.
  • ·Operations dependent on manufacturing and distribution agreement with GloBrands and its HUSTLER® license.
  • ·Cash increased to $9,589 from $0, funded by $1,378,147 related-party loans.
  • ·No cash paid for interest or income taxes in either year.
FIRST COMMONWEALTH FINANCIAL CORP /PA/DEFA14Aneutralmateriality 6/10

15-04-2026

First Commonwealth Financial Corporation supplemented its proxy statement for the April 28, 2026 Annual Meeting to disclose the hiring of Ryan L. Gorney as Executive Vice President and Chief Information Officer, effective around April 27, 2026; Ryan is the son of Director and Chairman Jon L. Gorney. This familial relationship will cause Jon L. Gorney to no longer qualify as an independent director under NYSE rules, prompting plans for a Lead Independent Director. The Board continues to recommend voting 'FOR ALL' director nominees, including Mr. Gorney whose term expires at the meeting.

  • ·Original Proxy Statement filed with SEC on March 19, 2026
  • ·Proxy materials available at www.envisionreports.com/FCF
Eaton Financial Holdings Company, LLC13F-HRneutralmateriality 6/10

15-04-2026

Eaton Financial Holdings Company, LLC filed a 13F-HR disclosing holdings in 125 securities with a total value of $305,429,092,000 as of March 31, 2026. The portfolio is heavily weighted toward ETFs, including top positions in Goldman Sachs ETF TR S&P 500 Premium (value $44,410,391,000), WisdomTree TR Floating Rate Treasury (value $16,285,293,000), and T Rowe Price ETF Inc US Equity Research (value $15,573,332,000). All positions are held with sole voting power.

  • ·Filing submitted on April 15, 2026, covering period ending March 31, 2026.
  • ·All 125 positions held with sole investment discretion and sole voting authority.
  • ·Portfolio includes significant exposure to tech (e.g., NVIDIA 44,679 shares, Microsoft 12,437 shares) and ETFs.
Targeted Financial Services LLC13F-HRneutralmateriality 4/10

15-04-2026

Targeted Financial Services LLC disclosed total holdings of $121,913,824 across 54 positions in its 13F-HR filing as of March 31, 2026, filed on April 15, 2026. The portfolio includes large-cap stocks such as Apple Inc (8154 shares, $2,069,405), Microsoft Corp (4454 shares, $1,648,883), and Walmart Inc (18807 shares, $2,337,333), alongside significant ETF positions like Fidelity Merrimack Street Trust Total Bond ETF ($24,336,885) and Goldman Sachs ActiveBeta US Large Cap ETF ($22,794,141). All holdings are reported with sole voting power and no put or call options.

  • ·Portfolio domiciled in Seminole, FL; filer EIN 223655368.
  • ·No shared voting or investment discretion reported on any holdings.
  • ·Smaller positions include Platinum Group Metals Ltd (26450 shares, $46,817) and Trilogy Metals Inc (51302 shares, $184,174).

Get daily alerts with 11 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 50 filings

🇺🇸 More from United States

View all →